RCW 74.09.559
170 words·~1 min read·
/wa/title-74/chapter-74-09/74-09-559·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
(1)The authority shall establish appropriate billing codes for hospitals and psychiatric hospitals that administer long-acting injectable buprenorphine on an outpatient basis to use for billing patients enrolled in a medical assistance program.
(2)Upon initiation or renewal of a contract with the authority to administer a medicaid managed care plan, a managed care organization must reimburse a hospital or psychiatric hospital that bills for the administration of long-acting injectable buprenorphine on an outpatient basis as a separate reimbursable expense.
(3)Beginning January 1, 2025, for individuals enrolled in a medical assistance program that is not a medicaid managed care plan, the authority must reimburse a hospital or psychiatric hospital that bills for the administration of long-acting injectable buprenorphine on an outpatient basis administered as a separate reimbursable expense.
(4)Reimbursements provided under this section must be separate from any bundled payment for outpatient hospital or emergency department services.
[ 2024 c 366 s 18 .]
Notes:
Findings — Intent — 2024 c 366: See note following RCW 71.24.847 .